Month: September 2022

TORONTO, Sept. 29, 2022 (GLOBE NEWSWIRE) — Reunion Neuroscience Inc. (TSX: REUN, NASDAQ: REUN) (“Reunion” or the “Company”) today announced the results of the votes held at its September 29, 2022 Annual General and Special Meeting of shareholders (the “Meeting”). The total number of common shares represented by shareholders present in person or by proxy at the Meeting was 5,073,132, representing 43.57% of the Company’s 11,642,953 outstanding common shares entitled to be voted. All of the matters put forward before the Company’s shareholders for consideration and approval, as set out in the Company’s Management Information Circular dated August 28, 2022 (the “Circular“), were approved by the requisite majority of votes cast at the Meeting. Each of the nominee directors listed in the Circular was...

(All dollar amounts are expressed in U.S. dollars, unless otherwise noted.) TORONTO, Sept. 29, 2022 (GLOBE NEWSWIRE) — Kinross Gold Corporation (“Kinross” or the “Company”) (TSX: K, NYSE: KGC) is pleased to announce that the Toronto Stock Exchange (the “TSX”) has accepted the notice filed by the Company to amend its normal course issuer bid (“NCIB”) program effective as of October 4, 2022. The amendment increases the maximum number of common shares that may be repurchased from 65,002,277 of its common shares (out of the 1,300,045,558 common shares outstanding as at July 27, 2022) representing 5% of the Company’s issued and outstanding common shares, to 114,047,070 of its common shares, representing 10% of the Company’s “public float” as at July 27, 2022. Purchases under the NCIB began on August 3, 2022 and will end no later than...

NEWTOWN, Pa., Sept. 29, 2022 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that Dane Andreeff, President and Chief Executive Officer, and Jeff Mathiesen, Chief Financial Officer, will present at the ROTH Capital Partners Inaugural Healthcare Opportunities Conference, as follows:Date: Thursday, October 6, 2022   Time: 8:45 AM ET   Location: The Yale Club, New York, NYInvestors and attendees who would like to schedule a 1-on-1 meeting with Helius management are asked to contact their Roth Capital representative to arrange a meeting.  About Helius Medical Technologies, Inc.Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using...

Medexus’s borrowing capacity under its revolving credit facility increases byUS$5.0 million, from US$20.0 million to US$25.0 million Transaction strengthens Medexus’s balance sheet, providing additional operating liquidity TORONTO and CHICAGO, Sept. 29, 2022 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals (Medexus) (TSX: MDP) (OTCQX: MEDXF) today entered into an amendment to the company’s revolving credit facility with a syndicate of lenders agented by MidCap Funding IV Trust (MidCap). Among other things, the amendment provides for a US$5.0 million increase in MidCap’s revolving loan commitment amount on substantially the same terms provided under the existing facility. Following the amendment, Medexus will have total borrowing capacity under the revolving credit facility of US$25.0 million subject to the borrowing base. “We are pleased...

TORONTO, Sept. 29, 2022 (GLOBE NEWSWIRE) — Theralase® Technologies Inc. (“Theralase” or “Company”) (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds (“PDCs”) and their associated drug formulations intended to safely and effectively destroy various cancers, announces that the Company proposes to extend the expiry date of 3,157,059 share purchase warrants, all of which are exercisable at $0.50 per share (collectively, the “Warrants”). The Warrants were issued on October 3, 2018 pursuant to a private placement involving the issuance of 3,157,059 units of the Company. The Warrants were previously amended to extend the original expiry date of October 3, 2020 to October 3, 2022. Now, the Company proposes to extend the amended expiry date...

Vancouver, B.C. , Sept. 29, 2022 (GLOBE NEWSWIRE) — Keon Capital Inc. (“Keon” or the “Company”) (TSXV: KEON.H) is pleased to announce that Luke Montaine has been added to the Company’s board of directors. Mr. Montaine already acts as the Company’s Chief Financial Officer and Corporate Secretary (see the Company’s press release dated July 4, 2022 respecting Mr. Montaine’s appointment to such positions and his qualifications). On behalf of the Board of Directors “John McCleery” Director and CEOTel: 604.880.5624Email: johnb.mccleery@gmail.com ### Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Not for distribution to U.S. news wire services or for dissemination in the United States Toronto, Ontario, Sept. 29, 2022 (GLOBE NEWSWIRE) — Avante Logixx Inc. (“Avante” or the “Company“) (TSXV: XX) is pleased to announce that it has entered into a non-binding letter of intent (the “Letter of Intent”) to acquire certain of the business and assets of C&B Alarms Ltd. (“C&B Alarms”). The parties currently intend to negotiate and enter into a definitive agreement for the Transaction (the “Agreement”), which will include customary terms and conditions for a transaction of this nature, including (i) completion of due diligence by the Company; and (ii) the receipt of all requisite corporate, shareholder and regulatory approvals. There can be no assurance that a definitive agreement will be negotiated...

Bombardier Introduces Innovator, Investor and F1 Team Owner Toto Wolff as Worldwide Brand Ambassador Bombardier Introduces Innovator, Investor and F1 Team Owner Toto Wolff as Worldwide Brand AmbassadorMONTREAL, Sept. 29, 2022 (GLOBE NEWSWIRE) — Bombardier today introduced Toto Wolff as its worldwide brand ambassador. For many years, Toto has turned to Bombardier jets to quickly, efficiently and smoothly travel between business and motorsport engagements around the world. With this longstanding experience in hand, Toto will support Bombardier through a range of activities and touchpoints. “Toto is a visionary leader and entrepreneur who embodies the spirit of innovation, excellence, performance and competitiveness that have all become synonymous with Bombardier business jets around the world,” said Éric Martel, President...